Intrinsic Value of S&P & Nasdaq Contact Us

Babylon Holdings Limited BBLN NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • GB • USD

SharesGrow Score
23/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Babylon Holdings Limited (BBLN) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 23/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
23/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
20/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
25/100
Debt-to-Equity & liquidity
→ Health
MOAT
27/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — BBLN

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-12.01
Book Value / Share$0.00
Revenue / Share$60.18
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-1.51 $16.03M $-140.29M -874.9%
2020 $-2.03 $79.27M $-188.03M -237.2%
2021 $-33.53 $322.92M $-374.51M -116%
2022 $-12.01 $1.11B $-221.45M -20%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message